In this article
Henry Meds describes one payment covering provider care, medication, and supplies, with several treatment choices and plan lengths. That bundle is the starting point for comparison, not proof that every route and prescription has the same price.
If you are considering an alternative, identify whether your concern is the medicine, the appointment process, or the next invoice. Each concern points to a different comparison and different questions for the receiving clinician.
Match the proposed medication and route, then compare the full bundle, follow-up format, and later refill terms. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.
What to know first
- Match the proposed medication and route, then compare the full bundle, follow-up format, and later refill terms.
- CoreAge Rx is the first listing through a disclosed commercial arrangement.
- Confirm the proposed product, care arrangement, and complete written payment terms.
How this shortlist was selected
CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.
Match the proposed medication and route, then compare the full bundle, follow-up format, and later refill terms. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.
01. CoreAge Rx — featured partner
Our sponsored self-pay comparison for readers examining another included-care offer. Confirm the complete term and proposed medication rather than comparing two starting headlines.
The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.
The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.
Continue with our CoreAge Rx review and pricing details.
02. LifeRx.md
Describes a required initial video consultation and no membership fee. Ask whether its ongoing contact format matches what you want from Henry’s bundled care.
LifeRx.md advertises GLP-1 treatment from $200, no higher-dose upcharges, and no membership or subscription fees. Its asterisk says pricing, eligibility, and other terms apply; the headline does not establish every treatment’s complete price or billing period.
Ask what the starting offer covers, the prescribed period, and any testing charge. Its 24/7 customer-support statement does not establish that a prescribing clinician is available around the clock.
Check the official LifeRx.md program page for the current offer and conditions. Our LifeRx.md alternatives comparison examines other care models.
03. NiceRx
A comparison with first-month and continuing prices separated. Budget using the continuing rate for the actual proposed medicine.
NiceRx lists semaglutide at $99 for the first month, then $199 per month, and tirzepatide at $199 for the first month, then $299. It says medication, provider access, and shipping are included.
Budget with the ongoing price, not just the first month. The page directs cancellation requests to email and says dispensed medication cannot be returned; confirm the order stage and next renewal separately.
Check the official NiceRx program page for the current offer and conditions. Our NiceRx alternatives comparison examines other care models.
04. Direct Meds
Offers sublingual and injectable options with different prices. This is relevant when route is the question, but product equivalence must not be assumed.
DirectMeds lists weight-loss treatment from $249 for sublingual semaglutide and $297 for injections. It also describes new-customer discounts and six- or 12-month bulk plans, so the selected route and term matter.
A compounded sublingual preparation is a different product from an approved oral tablet or an injection. Confirm the exact formulation, full bulk payment if selected, and refill arrangements before comparing prices.
Check the official Direct Meds program page for the current offer and conditions. Our Direct Meds alternatives comparison examines other care models.
05. Strut Health
Lists a compounded injection and a buccal lozenge separately. The lozenge’s formulation and evidence need their own clinical discussion.
Strut lists compounded injectable semaglutide at $129 for a monthly vial and a compounded oral buccal lozenge at $199 for a 30-day supply. It says physician consultations and shipping are included, with final pricing determined after assessment.
Compare like routes and exact formulations. A buccal lozenge is not the same product as an approved oral tablet, and evidence about an injection does not establish equivalent results for a lozenge. Check the next automatic-refill date.
Check the official Strut Health program page for the current offer and conditions. Our Strut Health alternatives comparison examines other care models.
06. Ro
A different product pathway for readers considering branded treatment and insurance assistance. Add the membership and medicine rather than comparing a care fee with a full Henry bundle.
Ro lists $39 for the first Body membership month, then $149 on a month-to-month plan, or an advertised monthly equivalent as low as $74 with annual prepayment. The cost of the medication is excluded.
For an insured prescription, Ro describes sending it to a pharmacy; cash-pay routes can differ. Confirm the pharmacy and whether your prescribed product is a manufacturer-labeled medicine. Do not use an old compounded-pricing article to identify the product in a new Ro checkout.
Continue with our Ro review and pricing details.
The current Henry Meds baseline
The weight-management FAQ lists GLP-1 treatment starting at $179 per month, with price varying by plan and dose. It describes the amount as including provider visits, medication, and supplies. The starting figure is not a quote for every medication, route, or dose.
Henry describes an online service in which medical forms lead to a provider assessment and, if appropriate, a prescription shipped with supplies. Its weight-management page says subscription offerings include care, medication, and supplies.
Henry says it works with licensed U.S. compounding pharmacies. The reviewed FAQ does not establish the identity and state authorization of every possible dispenser. Ask for the actual pharmacy attached to your prescription.
The details that decide this comparison
Henry’s listed GLP-1 starting price is not a quote for every route or dose. Ask for the exact continuing plan before comparing a competitor’s promotion.
Compare the provider appointment and later clinical contact separately. Included visits do not establish a particular follow-up frequency.
Check whether the alternative ships a starter package, a recurring monthly prescription, or a longer supply. Match the treatment period and ask what happens if the prescription changes.
Keep the treatment distinction clear
An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.
Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.
Before you make a change
Obtain a clear status for any pending Henry prescription before ordering from another provider. A new consultation does not automatically cancel an existing pharmacy order.
For a route or formulation change, let the new clinician review your records and provide new instructions. Do not carry over an old product’s directions because the ingredient name looks familiar.
Sources & research notes
Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
- CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
- CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
- CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
- CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
- LifeRx.md: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- NiceRx: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Direct Meds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: Wegovy semaglutide tablets, NDA 218316 approval letterRegulatory source · Checked September 21, 2026
- Strut Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Weight Loss - Ro Body Membership | RoProvider-published information · Checked September 21, 2026
- Ro - Telehealth for ED, Hair loss, Skincare, Fertility and MoreProvider-published information · Checked September 21, 2026
- GLP-1 Weight Loss Treatment | HenryProvider-published information · Checked September 21, 2026
- FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
- FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026
Read our methodology · Commercial disclosure · Request a correction